Related Experiment Video
Updated: Aug 8, 2026

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
Published on: December 3, 2010
Golgi complex is brefeldin A resistant in multidrug resistant cells
M V Erokhina1, A A Stavrovskaya, G E Onishchenko
1Institute of Carcinogenesis, Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow. rak@sunny.aha.ru
Abstract:
The multidrug resistance (MDR) is one of the main reasons for chemotherapeutic failures in cancer patients. The overexpression of mdr1 gene product, P-glycoprotein (Pgp), leads to the appearance of resistant tumor cells. In the previous paper (Erokhina, 1997) we have demonstrated that the first stages of Pgp-mediated MDR are accompanied by the reorganization of cytoskeleton elements and the vacuolar system. These data were true for two independently isolated sublines of Syrian hamster embryo fibroblasts transformed by Raus sarcoma virus. In this study, we continued the investigation of the properties of the vacuolar system in Pgp-expressing cells. Brefeldin A (BFA), which is not a Pgp substrate, affects different elements of the vacuolar system and blocks vesicular transport. Our data demonstrate that BFA has different effects on parental and resistant cells. In parental cells, the Golgi apparatus and vesicular transport are sensitive to BFA, while in resistant sublines, BFA affects the vesicular transport but not the Golgi apparatus structure. We discuss the existence of similar and different BFA targets in parental and resistant cells and their role in the evolution of multidrug resistance mechanisms.
Insights
Multidrug resistance (MDR) in cancer involves P-glycoprotein (Pgp). Brefeldin A (BFA) reveals distinct vacuolar system responses in Pgp-expressing cells, impacting cancer chemotherapy effectiveness.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Multidrug resistance (MDR) is a major cause of chemotherapy failure in cancer.
- Overexpression of P-glycoprotein (Pgp) confers MDR by enabling resistant tumor cells.
- Previous work showed Pgp-mediated MDR involves cytoskeleton and vacuolar system reorganization.
Purpose of the Study:
- To investigate vacuolar system properties in Pgp-expressing cells.
- To understand the effects of Brefeldin A (BFA) on parental and resistant cells.
- To explore the role of BFA targets in the evolution of MDR.
Main Methods:
- Utilized Syrian hamster embryo fibroblasts transformed by Raus sarcoma virus.
- Compared the effects of Brefeldin A (BFA) on parental and Pgp-expressing resistant sublines.
- Assessed BFA's impact on Golgi apparatus structure and vesicular transport.
Main Results:
- Brefeldin A (BFA) differentially affects parental and resistant cells.
- In parental cells, BFA impacts both Golgi apparatus structure and vesicular transport.
- In resistant cells, BFA affects vesicular transport but not Golgi apparatus structure.
Conclusions:
- Vacuolar system responses to BFA differ between parental and Pgp-expressing cells.
- These differences suggest distinct BFA targets contributing to MDR evolution.
- Understanding these mechanisms may offer new avenues for overcoming chemotherapy resistance.
Related Concept Videos
Golgi Apparatus
Vesicular Tubular Clusters
With the help of motor proteins such...
Golgi Apparatus
The Golgi apparatus is a eukaryotic organelle that has a distinctive ribbon-like appearance. It is a primary sorting and dispatch station for cargo arriving from the ER. Newly arriving vesicles enter the cis face of the Golgi, closest to the ER, and are...
Golgi Matrix Proteins
One of the first identified Golgi matrix proteins was GM130, a rod-like protein located in the cis-Golgi. Subsequently, many Golgi...
Transport Across the Golgi
Golgi Apparatus
The Golgi apparatus is a eukaryotic organelle that has a distinctive ribbon-like appearance. It is a primary sorting and dispatch station for cargo arriving from the ER. Newly arriving vesicles enter the cis face of the Golgi, closest to the ER, and are...

